CSIMarket Company Name, Ticker, Customers, else..


Abvc Biopharma Inc  (NASDAQ: ABVC)
Other Ticker:  
 

Abvc Biopharma Inc

ABVC's Fundamental analysis



Looking into Abvc Biopharma Inc growth rates, revenue grew by 6272.17 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 2784

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.76 %

Abvc Biopharma Inc net loss decreased from $-2 millions, to $0 millions in III. Quarter 2024,

• More on ABVC's Growth


Abvc Biopharma Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 20.39 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.82.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.


• More on ABVC's Valuation
 
 Total Debt (Millions $) 1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 18,052
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 3.19
 Tangible Book Value (Per Share $) 0.64

Abvc Biopharma Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 20.39 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.82.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.

Abvc Biopharma Inc Price to Book Ratio is at 1.1 lower than Industry Avg. of 91.98. and higher than S&P 500 Avg. of 0.01

• More on ABVC's Valuation

•  Market Capitalization (Millions $) 9
•  Shares Outstanding (Millions) 12
•  Employees 29
•  Revenues (TTM) (Millions $) 1
•  Net Income (TTM) (Millions $) -9
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) 1
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 18,052
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 3.19
•  Tangible Book Value (Per Share $) 0.64

•  Market Capitalization (Millions $) 9
•  Shares Outstanding (Millions) 12
•  Employees 29
•  Revenues (TTM) (Millions $) 1
•  Net Income (TTM) (Millions $) -9
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -


    ABVC's Profitability Comparisons
Abvc Biopharma Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 12.83 %.



  Ratio
•   Capital Ratio (MRQ) 0.34
•  Total Debt to Equity (MRQ) 0.11
•  Tangible Leverage Ratio (MRQ) 0.75
•  Asset Turnover Ratio (TTM) 0.03
•  Inventory Turnover Ratio (TTM) -



Abvc Biopharma Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 12.83 %.



• More on ABVC's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com